Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
31.9M
-
Shares change
-
+563K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
+$27.8M
-
Number of buys
-
38
-
Number of sells
-
-23
-
Price
-
$38.49
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q4 2019
69 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2019.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.9M shares
of 75.6M outstanding shares and own 42.22% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.41M shares), Bain Capital Life Sciences Investors, LLC (7.28M shares), PERCEPTIVE ADVISORS LLC (3.34M shares), BVF INC/IL (3.08M shares), BOXER CAPITAL, LLC (2.08M shares), FMR LLC (1.11M shares), CITADEL ADVISORS LLC (931K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (788K shares), Samsara BioCapital, LLC (654K shares), and BlackRock Inc. (641K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.